Literature DB >> 26895834

Healthy HLA-DQ2.5+ Subjects Lack Regulatory and Memory T Cells Specific for Immunodominant Gluten Epitopes of Celiac Disease.

Asbjørn Christophersen1, Louise F Risnes2, Elin Bergseng2, Knut E A Lundin3, Ludvig M Sollid2, Shuo-Wang Qiao2.   

Abstract

Celiac disease (CD) is an HLA-associated disorder characterized by a harmful T cell response to dietary gluten. It is not understood why most individuals who carry CD-associated HLA molecules, such as HLA-DQ2.5, do not develop CD despite continuous gluten exposure. In this study, we have used tetramers of HLA-DQ2.5 bound with immunodominant gluten epitopes to explore whether HLA-DQ2.5(+) healthy individuals mount a specific CD4(+) T cell response to gluten. We found that gluten tetramer-binding memory cells were rare in blood of healthy individuals. These cells showed lower tetramer-binding intensity and no signs of biased TCR usage compared with gluten tetramer-binding memory T cells from patients. After sorting and in vitro expansion, only 18% of the tetramer-binding memory cells from healthy subjects versus 79% in CD patients were gluten-reactive upon tetramer restaining. Further, T cell clones of tetramer-sorted memory cells of healthy individuals showed lower gluten-specific proliferative responses compared with those of CD patients, indicating that tetramer-binding memory cells in healthy control subjects may be cross-reactive T cells. In duodenal biopsy specimens of healthy control subjects, CD4(+) T cells were determined not to be gluten reactive. Finally, gluten tetramer-binding cells of healthy individuals did not coexpress regulatory T cell markers (Foxp3(+) CD25(+)) and cultured T cell clones did not express a cytokine profile that indicated immune-dampening properties. The results demonstrate that healthy HLA-DQ2.5(+) individuals do not mount a T cell response to immunodominant gluten epitopes of CD.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26895834     DOI: 10.4049/jimmunol.1501152

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  The roles of MHC class II genes and post-translational modification in celiac disease.

Authors:  Ludvig M Sollid
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

2.  Discriminative T-cell receptor recognition of highly homologous HLA-DQ2-bound gluten epitopes.

Authors:  Shiva Dahal-Koirala; Laura Ciacchi; Jan Petersen; Louise Fremgaard Risnes; Ralf Stefan Neumann; Asbjørn Christophersen; Knut E A Lundin; Hugh H Reid; Shuo-Wang Qiao; Jamie Rossjohn; Ludvig M Sollid
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

Review 3.  Single-cell approaches to dissect adaptive immune responses involved in autoimmunity: the case of celiac disease.

Authors:  Ida Lindeman; Ludvig M Sollid
Journal:  Mucosal Immunol       Date:  2021-09-16       Impact factor: 7.313

4.  Reduced frequency of circulating regulatory T cells and their related immunosuppressive mediators in treated celiac patients.

Authors:  Nastaran Asri; Mohammad Rostami-Nejad; Abdolrahim Nikzamir; Elham Aghamohamadi; Hamid Asadzadeh-Aghdaei; Mohammad Reza Zali
Journal:  Mol Biol Rep       Date:  2022-06-20       Impact factor: 2.742

5.  CD38 expression on gluten-specific T cells is a robust marker of gluten re-exposure in coeliac disease.

Authors:  Stephanie Zühlke; Louise Fremgaard Risnes; Shiva Dahal-Koirala; Asbjørn Christophersen; Ludvig M Sollid; Knut Ea Lundin
Journal:  United European Gastroenterol J       Date:  2019-09-07       Impact factor: 4.623

6.  Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions.

Authors:  Asbjørn Christophersen; Eivind G Lund; Omri Snir; Elsa Solà; Chakravarthi Kanduri; Shiva Dahal-Koirala; Stephanie Zühlke; Øyvind Molberg; Paul J Utz; Mina Rohani-Pichavant; Julia F Simard; Cornelia L Dekker; Knut E A Lundin; Ludvig M Sollid; Mark M Davis
Journal:  Nat Med       Date:  2019-03-25       Impact factor: 53.440

7.  Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial.

Authors:  Maureen M Leonard; Jocelyn A Silvester; Daniel Leffler; Alessio Fasano; Ciarán P Kelly; Suzanne K Lewis; Jeffrey D Goldsmith; Elliot Greenblatt; William W Kwok; William J McAuliffe; Kevin Galinsky; Jenifer Siegelman; I-Ting Chow; John A Wagner; Anna Sapone; Glennda Smithson
Journal:  Gastroenterology       Date:  2020-10-29       Impact factor: 22.682

Review 8.  Coeliac disease: a unique model for investigating broken tolerance in autoimmunity.

Authors:  Melinda Y Hardy; Jason A Tye-Din
Journal:  Clin Transl Immunology       Date:  2016-11-02

Review 9.  T Cells in Celiac Disease.

Authors:  Bana Jabri; Ludvig M Sollid
Journal:  J Immunol       Date:  2017-04-15       Impact factor: 5.422

Review 10.  Interplay Between Gluten, HLA, Innate and Adaptive Immunity Orchestrates the Development of Coeliac Disease.

Authors:  Jordan Voisine; Valérie Abadie
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.